Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic

Sahra Abdulle1, Lars Hagberg, Bo Svennerholm

  • 1Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden. sahra.abdulle@infect.gu.se

Plos One
|April 17, 2008
PubMed
Abstract

Insights

HIV subtypes do not affect central nervous system (CNS) infection markers. This study found no differences in cerebrospinal fluid (CSF) viral load, neopterin, or white blood cell counts among patients infected with various HIV-1 subtypes.

Area of Science:

  • Neurovirology
  • Immunology
  • Genetics

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) has significant genetic diversity, grouped into M, N, and O.
  • Group M, responsible for the global epidemic, includes multiple subtypes and recombinant forms.
  • Current understanding of HIV-1 central nervous system (CNS) infection primarily relies on subtype B, despite other subtypes being more prevalent globally.

Purpose of the Study:

  • To investigate the influence of different HIV-1 subtypes on cerebrospinal fluid (CSF) markers of CNS infection.
  • To determine if HIV-1 genetic diversity impacts neurological disease markers.

Main Methods:

  • Measurement of CSF HIV-1 RNA, neopterin, and white blood cell (WBC) counts in patients with diverse HIV-1 subtypes.
  • Application of multivariate regression analysis to compare marker levels across subtypes.

Main Results:

  • No statistically significant differences were observed in CSF WBC count among different HIV-1 subtypes.
  • CSF neopterin levels did not vary significantly based on the infecting HIV-1 subtype.
  • Cerebrospinal fluid HIV-1 viral load showed no subtype-dependent variations.

Conclusions:

  • The study found no evidence of subtype-dependent differences in the evaluated CSF markers of HIV-1 CNS infection.
  • These findings suggest that HIV-1 genetic subtypes may not significantly alter the inflammatory or viral markers within the CNS.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...